{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:33:34Z","timestamp":1784709214246,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94923-0","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T20:18:12Z","timestamp":1743797892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PET imaging of differentiated thyroid cancer with thyrotropin-alfa"],"prefix":"10.1038","volume":"15","author":[{"given":"Grayson R.","family":"Gimblet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratheek","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey A.","family":"Houson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Whitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad S.","family":"Kenderian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Jaskula-Sztul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Lapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"94923_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. Cancer J. Clin. 73, 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"Cancer J. Clin."},{"key":"94923_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch, Z. W. et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33, 27\u201363. https:\/\/doi.org\/10.1007\/s12022-022-09707-3 (2022).","journal-title":"Endocr. Pathol."},{"key":"94923_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.epi-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara, C. M. & Schneider, A. B. Epidemiology of thyroid cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer.Research. Cosponsored Am. Soc. Prev. Oncol. 31, 1284\u20131297. https:\/\/doi.org\/10.1158\/1055-9965.epi-21-1440 (2022).","journal-title":"Cosponsored Am. Soc. Prev. Oncol."},{"key":"94923_CR4","doi-asserted-by":"publisher","unstructured":"Haugen, B. R. et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid: official journal of the American Thyroid Association 26, 1-133, (2015). https:\/\/doi.org\/10.1089\/thy.2015.0020 (2016).","DOI":"10.1089\/thy.2015.0020"},{"key":"94923_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2967\/jnumed.121.262402","volume":"63","author":"AM Avram","year":"2022","unstructured":"Avram, A. M., Zukotynski, K., Nadel, H. R. & Giovanella, L. Management of differentiated thyroid cancer: the standard of care. J. Nuclear Medicine: Official Publication Soc. Nuclear Med. 63, 189\u2013195. https:\/\/doi.org\/10.2967\/jnumed.121.262402 (2022).","journal-title":"J. Nuclear Medicine: Official Publication Soc. Nuclear Med."},{"key":"94923_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"RM Tuttle","year":"2019","unstructured":"Tuttle, R. M. et al. Controversies, consensus, and collaboration in the use of (131)I therapy in differentiated thyroid cancer: A joint statement from the American thyroid association, the European association of nuclear medicine, the society of nuclear medicine and molecular imaging, and the European thyroid association. Thyroid: Official J. Am. Thyroid Association. 29, 461\u2013470. https:\/\/doi.org\/10.1089\/thy.2018.0597 (2019).","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"94923_CR7","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante, C. et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892\u20132899. https:\/\/doi.org\/10.1210\/jc.2005-2838 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94923_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1758834014548188","volume":"6","author":"F Worden","year":"2014","unstructured":"Worden, F. Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer. Therapeutic Adv. Med. Oncol. 6, 267\u2013279. https:\/\/doi.org\/10.1177\/1758834014548188 (2014).","journal-title":"Therapeutic Adv. Med. Oncol."},{"key":"94923_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1089\/thy.2011.0535","volume":"22","author":"IJ Nixon","year":"2012","unstructured":"Nixon, I. J. et al. The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. Thyroid: Official J. Am. Thyroid Association. 22, 884\u2013889. https:\/\/doi.org\/10.1089\/thy.2011.0535 (2012).","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"94923_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fendo.2017.00086","volume":"8","author":"G Kleinau","year":"2017","unstructured":"Kleinau, G. et al. Structural-Functional features of the Thyrotropin receptor: A class A G-Protein-Coupled receptor at work. Front. Endocrinol. 8, 86. https:\/\/doi.org\/10.3389\/fendo.2017.00086 (2017).","journal-title":"Front. Endocrinol."},{"key":"94923_CR11","doi-asserted-by":"publisher","unstructured":"Galli, F. et al. In vivo imaging of thyroid cancer with (99m)Tc-TR1401 and (99m)Tc-TR1402: A comparison study in dogs. J. Clin. Med. 10 https:\/\/doi.org\/10.3390\/jcm10091878 (2021).","DOI":"10.3390\/jcm10091878"},{"key":"94923_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.surg.2023.05.045","volume":"175","author":"GR Gimblet","year":"2024","unstructured":"Gimblet, G. R. et al. Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer. Surgery 175, 199\u2013206. https:\/\/doi.org\/10.1016\/j.surg.2023.05.045 (2024).","journal-title":"Surgery"},{"key":"94923_CR13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00224","author":"GR Gimblet","year":"2024","unstructured":"Gimblet, G. R. et al. PET imaging of differentiated thyroid cancer with TSHR-Targeted [(89)Zr]Zr-TR1402. Mol. Pharm. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00224 (2024).","journal-title":"Mol. Pharm."},{"key":"94923_CR14","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1021\/acs.jmedchem.4c01525","volume":"67","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Targeting Thyroid-Stimulating hormone receptor: A perspective on Small-Molecule modulators and their therapeutic potential. J. Med. Chem. 67, 16018\u201316034. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01525 (2024).","journal-title":"J. Med. Chem."},{"key":"94923_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1210\/clinem\/dgab819","volume":"107","author":"H Li","year":"2022","unstructured":"Li, H. et al. CAR-T cells targeting TSHR demonstrate safety and potent preclinical activity against differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 107, 1110\u20131126. https:\/\/doi.org\/10.1210\/clinem\/dgab819 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94923_CR16","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1210\/jcem.84.11.6094","volume":"84","author":"BR Haugen","year":"1999","unstructured":"Haugen, B. R. et al. A comparison of Recombinant human Thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J. Clin. Endocrinol. Metab. 84, 3877\u20133885. https:\/\/doi.org\/10.1210\/jcem.84.11.6094 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94923_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1089\/thy.2008.0162","volume":"18","author":"BR Haugen","year":"2008","unstructured":"Haugen, B. R. et al. Expanding indications for Recombinant human TSH in thyroid cancer. Thyroid: Official J. Am. Thyroid Association. 18, 687\u2013694. https:\/\/doi.org\/10.1089\/thy.2008.0162 (2008).","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"94923_CR18","doi-asserted-by":"publisher","unstructured":"Coerts, H. I., de Keizer, B., Marlowe, R. J. & Verburg, F. A. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies. Eur. J. Endocrinol. 188 https:\/\/doi.org\/10.1093\/ejendo\/lvad006 (2023).","DOI":"10.1093\/ejendo\/lvad006"},{"key":"94923_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/108497804773391685","volume":"19","author":"F Corsetti","year":"2004","unstructured":"Corsetti, F. et al. Radioiodinated Recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection. Cancer Biother. Radiopharm. 19, 57\u201363. https:\/\/doi.org\/10.1089\/108497804773391685 (2004).","journal-title":"Cancer Biother. Radiopharm."},{"key":"94923_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MNM.0b013e3282f3a515","volume":"29","author":"A Rahmim","year":"2008","unstructured":"Rahmim, A. & Zaidi, H. PET versus SPECT: strengths, limitations and challenges. Nucl. Med. Commun. 29, 193\u2013207. https:\/\/doi.org\/10.1097\/MNM.0b013e3282f3a515 (2008).","journal-title":"Nucl. Med. Commun."},{"key":"94923_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nucmedbio.2017.03.004","volume":"50","author":"SL Queern","year":"2017","unstructured":"Queern, S. L. et al. Production of Zr-89 using sputtered yttrium coin targets (89)Zr using sputtered yttrium coin targets. Nucl. Med. Biol. 50, 11\u201316. https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.03.004 (2017).","journal-title":"Nucl. Med. Biol."},{"key":"94923_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/ph5010079","volume":"5","author":"AJ Chang","year":"2012","unstructured":"Chang, A. J. et al. 89Zr-Radiolabeled trastuzumab imaging in orthotopic and metastatic breast tumors. Pharmaceuticals (Basel Switzerland). 5, 79\u201393. https:\/\/doi.org\/10.3390\/ph5010079 (2012).","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"key":"94923_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/thy.2007.0097","volume":"17","author":"AM Meireles","year":"2007","unstructured":"Meireles, A. M. et al. Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid: Official J. Am. Thyroid Association. 17, 707\u2013715. https:\/\/doi.org\/10.1089\/thy.2007.0097 (2007).","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"94923_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/thy.2009.0195","volume":"19","author":"T Pilli","year":"2009","unstructured":"Pilli, T., Prasad, K. V., Jayarama, S., Pacini, F. & Prabhakar, B. S. Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer. Thyroid: Official J. Am. Thyroid Association. 19, 1333\u20131342. https:\/\/doi.org\/10.1089\/thy.2009.0195 (2009).","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"94923_CR25","doi-asserted-by":"publisher","first-page":"8113","DOI":"10.1158\/0008-5472.can-06-4026","volume":"67","author":"WC van Staveren","year":"2007","unstructured":"van Staveren, W. C. et al. Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res. 67, 8113\u20138120. https:\/\/doi.org\/10.1158\/0008-5472.can-06-4026 (2007).","journal-title":"Cancer Res."},{"key":"94923_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1385\/0-89603-441-0:163","volume":"75","author":"DW Williams","year":"1997","unstructured":"Williams, D. W. & Wynford-Thomas, D. Human thyroid epithelial cells. Methods Mol. Biology (Clifton N J). 75, 163\u2013172. https:\/\/doi.org\/10.1385\/0-89603-441-0:163 (1997).","journal-title":"Methods Mol. Biology (Clifton N J)"},{"key":"94923_CR27","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1210\/jc.2017-01845","volume":"103","author":"LA Marlow","year":"2018","unstructured":"Marlow, L. A. et al. Methodology, criteria, and characterization of Patient-Matched thyroid cell lines and Patient-Derived tumor xenografts. J. Clin. Endocrinol. Metab. 103, 3169\u20133182. https:\/\/doi.org\/10.1210\/jc.2017-01845 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94923_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/978-3-642-83816-3_6","volume":"118","author":"PE Goretzki","year":"1990","unstructured":"Goretzki, P. E., Frilling, A., Simon, D. & Roeher, H. D. Growth regulation of normal thyroids and thyroid tumors in man. Recent. Results cancer Res. Fortschr. Der Krebsforschung Progres Dans Les Recherches Sur Le cancer. 118, 48\u201363. https:\/\/doi.org\/10.1007\/978-3-642-83816-3_6 (1990).","journal-title":"Recent. Results cancer Res. Fortschr. Der Krebsforschung Progres Dans Les Recherches Sur Le cancer"},{"key":"94923_CR29","volume-title":"PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [ 89 Zr]Zr-TR1402","author":"GR Gimblet","year":"2024","unstructured":"Gimblet, G. R. et al. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [89Zr]Zr-TR1402 (Molecular pharmaceutics Accepted for Publication, 2024)."},{"key":"94923_CR30","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1530\/erc-11-0068","volume":"18","author":"HJ Song","year":"2011","unstructured":"Song, H. J., Xue, Y. L., Xu, Y. H., Qiu, Z. L. & Luo, Q. Y. Rare metastases of differentiated thyroid carcinoma: pictorial review. Endocr. Relat. Cancer. 18, R165\u2013174. https:\/\/doi.org\/10.1530\/erc-11-0068 (2011).","journal-title":"Endocr. Relat. Cancer"},{"key":"94923_CR31","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1021\/acs.molpharmaceut.3c00360","volume":"20","author":"M Ducharme","year":"2023","unstructured":"Ducharme, M. et al. Evaluation of [(89)Zr]Zr-DFO-2Rs15d nanobody for imaging of HER2-Positive breast cancer. Mol. Pharm. 20, 4629\u20134639. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00360 (2023).","journal-title":"Mol. Pharm."},{"key":"94923_CR32","doi-asserted-by":"publisher","first-page":"15384","DOI":"10.1038\/s41598-021-94887-x","volume":"11","author":"BB Kasten","year":"2021","unstructured":"Kasten, B. B. et al. Positron emission tomography imaging with (89)Zr-labeled anti-CD8 cys-diabody reveals CD8(+) cell infiltration during oncolytic virus therapy in a glioma murine model. Sci. Rep. 11, 15384. https:\/\/doi.org\/10.1038\/s41598-021-94887-x (2021).","journal-title":"Sci. Rep."},{"key":"94923_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/109158101317097746","volume":"20","author":"R Czerniak","year":"2001","unstructured":"Czerniak, R. Gender-based differences in pharmacokinetics in laboratory animal models. Int. J. Toxicol. 20, 161\u2013163. https:\/\/doi.org\/10.1080\/109158101317097746 (2001).","journal-title":"Int. J. Toxicol."},{"key":"94923_CR34","doi-asserted-by":"publisher","first-page":"27457","DOI":"10.1074\/jbc.M003707200","volume":"275","author":"H Leitolf","year":"2000","unstructured":"Leitolf, H., Tong, K. P., Grossmann, M., Weintraub, B. D. & Szkudlinski, M. W. Bioengineering of human Thyrotropin superactive analogs by site-directed lysine-scanning mutagenesis. Cooperative effects between peripheral loops. J. Biol. Chem. 275, 27457\u201327465. https:\/\/doi.org\/10.1074\/jbc.M003707200 (2000).","journal-title":"J. Biol. Chem."},{"key":"94923_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/thy.2010.0394","volume":"21","author":"J Reinfelder","year":"2011","unstructured":"Reinfelder, J. et al. Effects of Recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and Radioiodide. Thyroid: Official J. Am. Thyroid Association. 21, 783\u2013792. https:\/\/doi.org\/10.1089\/thy.2010.0394 (2011).","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"94923_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41586-022-05159-1","volume":"609","author":"B Faust","year":"2022","unstructured":"Faust, B. et al. Autoantibody mimicry of hormone action at the Thyrotropin receptor. Nature 609, 846\u2013853. https:\/\/doi.org\/10.1038\/s41586-022-05159-1 (2022).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94923-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94923-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94923-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T20:18:21Z","timestamp":1743797901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94923-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94923"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94923-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11375"}}